Patrick Kemmeren

Associate Professor

Universitair Medisch Centrum Utrecht

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Patrick Kemmeren is an Associate Professor at Universitair Medisch Centrum Utrecht in the Netherlands. His research focuses on pediatric oncology, precision medicine, and the molecular characterization of childhood cancers, as evidenced by his recent articles on pharmacogenetics, organoid models, and gene fusion detection. With a commitment to improving therapeutic strategies for children with cancer, he explores innovative approaches to integrate genomic data into clinical practice.

Articles (11)

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Josephine Daub

Assistant Professor

Utrecht University

NETHERLANDS

View details

Bastiaan Tops

Head of laboratory for childhood cancer pathology

Prinses Máxima Centrum voor Kinderoncologie

NETHERLANDS

View details

Jesse Swen

Full professor of clinical pharmacy, in particular translational pharmacogenetics

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick Kemmeren

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects

Trecode: A FAIR Eco-System for the Analysis and Archiving of Omics Data in a Combined Diagnostic and Research Setting

Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’

Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes

Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing

A systematic analysis of genetic interactions and their underlying biology in childhood cancer

Suboptimal Global Transcriptional Response Increases the Harmful Effects of Loss-of-Function Mutations

Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology

An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity

Genome‐wide off‐rates reveal how DNA binding dynamics shape transcription factor function

Collaborators (3)

Josephine Daub

Bastiaan Tops

Jesse Swen

Make your next move.